Total submissions: 6
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Gene |
RCV000443095 | SCV000532690 | likely benign | not specified | 2016-10-07 | criteria provided, single submitter | clinical testing | This variant is considered likely benign or benign based on one or more of the following criteria: it is a conservative change, it occurs at a poorly conserved position in the protein, it is predicted to be benign by multiple in silico algorithms, and/or has population frequency not consistent with disease. |
Labcorp Genetics |
RCV000663142 | SCV003468288 | likely benign | Familial cancer of breast | 2025-01-07 | criteria provided, single submitter | clinical testing | |
Myriad Genetics, |
RCV000663142 | SCV004019192 | uncertain significance | Familial cancer of breast | 2023-03-30 | criteria provided, single submitter | clinical testing | This variant is classified as a variant of uncertain significance as there is insufficient evidence to determine its impact on protein function and/or cancer risk. |
Color Diagnostics, |
RCV003584602 | SCV004357908 | likely benign | Hereditary cancer-predisposing syndrome | 2022-09-20 | criteria provided, single submitter | clinical testing | |
Department of Pathology and Laboratory Medicine, |
RCV005355771 | SCV005920672 | likely benign | PALB2-related cancer predisposition | 2023-11-24 | criteria provided, single submitter | clinical testing | |
Counsyl | RCV000663142 | SCV000786289 | likely benign | Familial cancer of breast | 2018-04-10 | no assertion criteria provided | clinical testing | This submission and the accompanying classification are no longer maintained by the submitter. For more information on current observations and classification, please contact variantquestions@myriad.com. |